Data / Drug companies / Nomax Inc.
Nomax Inc.: 16 products in the FDA NDC directory, labeler code 51801
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Nomax Inc. (labeler code 51801) lists 16 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 12 prescription drugs, 4 over the counter drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on April 29, 2024.
The request: Watch Nomax Inc. (FDA labeler code 51801): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 51801
- Products in commercial distribution
- 16
- Packages
- 19
- Finished drugs by generic name
- 5
- Prescription products
- 12
- Over the counter products
- 4
- Flagged as original packager
- 13 of 13 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 30, 2013
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 12 | 75% |
| Over the counter monograph drugs | 4 | 25% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 12 | 75% |
| Over the counter drugs | 4 | 25% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Potassium bicarbonate | 8 | 2 |
| Fluorescein sodium | 3 | 2 |
| Alcohol | 3 | 293 |
| Glycerin | 1 | 56 |
| Rose bengal sodium | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, effervescent | 8 | 50% |
| Strip | 4 | 25% |
| Solution/ drops | 1 | 6.2% |
| Solution | 1 | 6.2% |
| Gel | 1 | 6.2% |
| Spray | 1 | 6.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Viva Hydration Boost | 51801-016 | Solution/ drops | Over the counter monograph drugs | April 29, 2024 |
| Amcon Labs Hand Sanitizer Light Cleansing | 51801-779 | Spray | Over the counter monograph drugs | August 4, 2023 |
| Amcon Labs Hand Sanitizer Fragrance Free Gel Sanitizer | 51801-437 | Gel | Over the counter monograph drugs | August 4, 2023 |
| Amcon Labs Hand Sanitizer Instant Foam Sanitizer with Alcohol | 51801-366 | Solution | Over the counter monograph drugs | August 4, 2023 |
| Dry Eye Test | 51801-008 | Strip | Other unapproved drugs | December 5, 2013 |
| GloStrips | 51801-004 | Strip | Other unapproved drugs | August 20, 2013 |
| GloStrips | 51801-009 | Strip | Other unapproved drugs | July 30, 2013 |
| GloStrips | 51801-003 | Strip | Other unapproved drugs | July 30, 2013 |
| Effer-K 10 mEq Cherry Vanilla | 51801-014 | Tablet, effervescent | Other unapproved drugs | January 30, 2013 |
| Effer-K 10 mEq Unflavored | 51801-013 | Tablet, effervescent | Other unapproved drugs | January 30, 2013 |
| Effer-K 20 mEq Orange Cream | 51801-012 | Tablet, effervescent | Other unapproved drugs | January 30, 2013 |
| Effer-K 20 mEq Unflavored | 51801-011 | Tablet, effervescent | Other unapproved drugs | January 30, 2013 |
| Effer-K Unflavored | 51801-007 | Tablet, effervescent | Other unapproved drugs | January 30, 2013 |
| Effer-K Cherry Berry | 51801-006 | Tablet, effervescent | Other unapproved drugs | January 30, 2013 |
| Effer-K Lemon Citrus | 51801-005 | Tablet, effervescent | Other unapproved drugs | January 30, 2013 |
| Effer-K Orange | 51801-001 | Tablet, effervescent | Other unapproved drugs | January 30, 2013 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.